Lactose (India)

Lactose (India) OCF Margin

The Operating Cash Flow Margin of Lactose (India) (524202.BO) as of Nov 13, 2026 is 3.40 %. In the previous year, Operating Cash Flow Margin was -0.25 % — a change of -1,454.66% (higher).

OCF Margin

3.40 %

YoY

-1,454.66%

Last updated:

Operating Cash Flow Margin of Lactose (India) is 2026 3.40 % . Operating Cash Flow Margin of Lactose (India) was 2025 -0.25 % . It decreases by -1,454.66% higher compared to the previous year.

The Lactose (India) OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
12.15 INR
Jan 1, 2020
18.92 INR
Jan 1, 2021
6.19 INR
Jan 1, 2022
18.43 INR
Jan 1, 2023
12.25 INR
Jan 1, 2024
7.71 INR
Jan 1, 2025
-0.25 INR
Jan 1, 2026
3.40 INR
The Lactose (India) OCF Margin history
YEAROCF MarginYoY
3.40 %-1,454.66%
-0.25 %-103.26%
7.71 %-37.08%
12.25 %-33.56%
18.43 %+197.63%
6.19 %-67.27%
18.92 %+55.70%
12.15 %+2,265.33%
0.51 %-97.56%
21.09 %+392.28%
4.29 %-92.03%
53.78 %+60.52%
33.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lactose (India) Stock analysis

What does Lactose (India) do? Lactose India Ltd. generates revenue through the manufacturing of pharmaceutical products, primarily lactose monohydrate and disaccharide lactulose. The company produces dry granulated, film and lacquer coated tablets, and offers prebiotic-galacto-oligosaccharides (GOS) for applications in dairy, beverages, bakery, infant nutrition, clinical nutrition, children's products, and geriatric nutrition. Its plant in Vadodara, Gujarat, has an installed capacity of 180 metric tons annually for pharma color coatings. The firm serves segments including liquid dosage forms, solid dosage forms, excipients, and active pharmaceutical ingredients. The company's main products are lactose monohydrate, lactulose, and GOS, which are sold to pharmaceutical manufacturers and food industry players. Lactose monohydrate is used as an excipient in solid dosage forms, while lactulose serves as an active pharmaceutical ingredient. GOS is marketed for use in infant nutrition, clinical nutrition, and other food applications. The plant in Vadodara supports production of these products alongside pharma color coatings. Lactose India Ltd. targets pharmaceutical companies requiring excipients and active ingredients, as well as food and beverage manufacturers seeking prebiotic additives. The firm's product range includes lactose monohydrate for solid dosage forms, lactulose for active pharmaceutical ingredients, and GOS for nutritional applications across multiple consumer segments. Its production capabilities support the growing demand for pharmaceutical and functional food ingredients in India. Lactose (India) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lactose (India) stock

Operating Cash Flow Margin of Lactose (India) is 3.40 % in 2026.

Operating Cash Flow Margin of Lactose (India) changed from -0.25 % to 3.40 %, representing a -1,454.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Lactose (India) since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Lactose (India) with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Lactose (India)

All Key Metrics — Lactose (India)